Quality is our promise.

Call us today! 1-888-502-2050

24

June
2015

FDA Releases New Guidance for Compounding Animal Drugs from Bulk Drug Substances

June 24, 2015 Animal Compounders Fear the End is Near & Begin to Fight Their Losing Battle A few weeks ago the FDA released their latest guidance, #230 Guidance for Industry Compounding Animal Drugs from Bulk Drug Substances and animal compounders are very concerned at what this means for their futures. All guidances reflect the […]

read more

9

June
2015

category:

503b Compounding

Ophthalmologists and Patients Demand Quality Compounded Drugs at Affordable Prices

Access to compounding medications critical for ophthalmologists, patients http://www.healio.com/ophthalmology/practice-management/news/print/ocular-surgery-news/%7Bebef4371-1c0c-460d-b3cb-6e8d524915e2%7D/access-to-compounded-medications-critical-for-ophthalmologists-patients?page=1 Ocular Surgery News U.S. Edition, May 25, 2015 Richard L. Lindstrom, MD The decisions the FDA makes are critical to ophthalmologists and patients, especially in the anti-VEGF category. As I mentioned above, no generic anti-VEGF injectables are available. Lucentis (ranibizumab, Genentech) and Eylea, branded and patent-protected […]

read more